ROBINUL 0.2mg / ml solution for injection medication leaflet

A03AB02 • glycopyrronium bromide • Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, quaternary ammonium compounds

Glycopyrronium bromide is an anticholinergic medication primarily used for the treatment of obstructive respiratory diseases, such as chronic obstructive pulmonary disease (COPD). It works by blocking muscarinic receptors in the airways, leading to relaxation of bronchial smooth muscles and airway dilation, making breathing easier.

It is indicated for:

- Maintenance treatment of COPD to relieve symptoms such as shortness of breath.
- Reducing the frequency of disease exacerbations.

Glycopyrronium bromide is administered via an inhaler, usually once daily, as directed by a doctor.

Side effects may include dry mouth, throat irritation, cough, constipation, headache, or, rarely, allergic reactions. It is contraindicated in patients with hypersensitivity to glycopyrronium or other anticholinergics and should be used with caution in those with narrow-angle glaucoma, urinary retention, or other conditions that may be worsened by anticholinergic effects.